A multidisciplinary panel of oncologists opens this OncLive Peer Exchange on evolving strategies in neuroendocrine tumor management, introducing the faculty and framing the discussion around CABINET trial data and current clinical practice.
Evolving Strategies in Neuroendocrine Tumor Management
The panel examines how treatment is selected across the disease course in neuroendocrine tumors, beginning with the distinction between early-stage and advanced disease.
Advertisement
Advertisement
Trending on OncLive
1
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer
2
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer
3
Zongertinib, Sevabertinib Reshape Treatment Landscape for Patients With HER2-Mutated NSCLC
4
Bulumtatug Fuvedotin Yields 32% ORR as First Nectin-4 ADC With Data in Cervical Cancer
5